Viropro Inc (VPRO) 0.0020 $VPRO
Letter of Intent to Acquire NovaRx Expires; Viropro Appoints New Slate of Officers
PR Newswire - Mon May 02, 8:28AM CDT
Viropro, Inc. (OTCBB: VPRO) today announced that the non-binding Letter of Intent (the "LOI"
the Company had signed in October 2015 to acquire NovaRx LLC ("NovaRx" has expired and that the acquisition contemplated in the LOI has not been consummated.
Hidden Market Patterns, History Repeats Itself - Analyst Notes on Viropro, Baristas Coffee Company, Endonovo Therapeutics and Bayerische Motoren Werke
ACCESSWIRE - Mon Mar 14, 6:55AM CDT
NEW YORK, NY / ACCESSWIRE / March 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Viropro Inc. (OTC: VPRO), Baristas Coffee Company Inc. (OTC: BCCID), Endonovo Therapeutics Inc. (OTC: ENDV) and Bayerische Motoren Werke AG (OTC: BAMXY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Equities Lead Investor Sentiment -- Complementary Research on Hybrid Coating Technologies, Viropro, Ekso Bionics Holdings and Hong Kong and China Gas
ACCESSWIRE - Thu Jan 14, 7:20AM CST
NEW YORK, NY / ACCESSWIRE / January 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Hybrid Coating Technologies Inc. (OTC: HCTI), Viropro Inc. (OTC: VPRO), Ekso Bionics Holdings Inc. (OTC: EKSO) and Hong Kong and China Gas Co. Ltd. (OTC: HOKCY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Dr. Ivor Royston, Oncologist, Entrepreneur, Investor and a Founder of San Diego Biotech, Joins Viropro Board
PR Newswire - Tue Dec 08, 8:00AM CST
Viropro, Inc. (OTCBB: VPRO), which has previously announced it will be changing its name to Axxiom, today announced that Ivor Royston, M.D. has agreed to join its Board of Directors effective immediately.
LLY: 79.66 (+0.34)
Viropro Announces Signing of Letter of Intent to Acquire NovaRx
PR Newswire - Thu Oct 22, 6:58PM CDT
Viropro, Inc. (OTCBB: VPRO) today announced that it has signed a non-binding Letter of Intent (the "LOI" for the acquisition of NovaRx, a San Diego based pioneer in immuno-oncology, in an all-stock transaction that is expected to close by year-end, subject to the approval by both companies of definitive documents and the achievement of certain other milestones. The Letter of Intent is non-binding and may be terminated by either party based on failure to comply with its terms or upon 30 days written notice by either party.
Viropro Announces Results of Strategic Review and Plan for Restructuring
PR Newswire - Mon Feb 02, 12:51PM CST
Viropro, Inc. (OTCBB: VPRO) today announced that its Board of Directors completed its strategic review and has begun the implementation of a restructuring designed to restore the company to financial health.
Viropro Opposes Sale of Alpha Assets by Receiver and Manager Action Follows Seizure of Assets by Bank Pembangunan
PR Newswire - Wed Dec 24, 3:16AM CST
Viropro, Inc. (OTCBB: VPRO) today announced its concern that the proposed sale by a Receiver and Manager appointed by Bank Pembangunan Malaysia Berhad (BPMB) of substantially all the assets of Alpha Biologics Sdn Bhd (Alpha), a wholly owned subsidiary of Viropro located in Penang, Malaysia, would cause irreparable hard to Viropro and the other creditors of Alpha. BPMB previously seized the Alpha facility and appointed Lim San Peen of PricewaterhouseCoopers Advisory Services Sdn Bhd as Receiver and Manager.
Letter of Intent to Acquire NovaRx Expires; Viropro Appoints New Slate of Officers
PR Newswire - Mon May 02, 8:28AM CDT
Viropro, Inc. (OTCBB: VPRO) today announced that the non-binding Letter of Intent (the "LOI"
the Company had signed in October 2015 to acquire NovaRx LLC ("NovaRx" has expired and that the acquisition contemplated in the LOI has not been consummated. Hidden Market Patterns, History Repeats Itself - Analyst Notes on Viropro, Baristas Coffee Company, Endonovo Therapeutics and Bayerische Motoren Werke
ACCESSWIRE - Mon Mar 14, 6:55AM CDT
NEW YORK, NY / ACCESSWIRE / March 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Viropro Inc. (OTC: VPRO), Baristas Coffee Company Inc. (OTC: BCCID), Endonovo Therapeutics Inc. (OTC: ENDV) and Bayerische Motoren Werke AG (OTC: BAMXY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Equities Lead Investor Sentiment -- Complementary Research on Hybrid Coating Technologies, Viropro, Ekso Bionics Holdings and Hong Kong and China Gas
ACCESSWIRE - Thu Jan 14, 7:20AM CST
NEW YORK, NY / ACCESSWIRE / January 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Hybrid Coating Technologies Inc. (OTC: HCTI), Viropro Inc. (OTC: VPRO), Ekso Bionics Holdings Inc. (OTC: EKSO) and Hong Kong and China Gas Co. Ltd. (OTC: HOKCY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Dr. Ivor Royston, Oncologist, Entrepreneur, Investor and a Founder of San Diego Biotech, Joins Viropro Board
PR Newswire - Tue Dec 08, 8:00AM CST
Viropro, Inc. (OTCBB: VPRO), which has previously announced it will be changing its name to Axxiom, today announced that Ivor Royston, M.D. has agreed to join its Board of Directors effective immediately.
LLY: 79.66 (+0.34)
Viropro Announces Signing of Letter of Intent to Acquire NovaRx
PR Newswire - Thu Oct 22, 6:58PM CDT
Viropro, Inc. (OTCBB: VPRO) today announced that it has signed a non-binding Letter of Intent (the "LOI"
for the acquisition of NovaRx, a San Diego based pioneer in immuno-oncology, in an all-stock transaction that is expected to close by year-end, subject to the approval by both companies of definitive documents and the achievement of certain other milestones. The Letter of Intent is non-binding and may be terminated by either party based on failure to comply with its terms or upon 30 days written notice by either party. Viropro Announces Results of Strategic Review and Plan for Restructuring
PR Newswire - Mon Feb 02, 12:51PM CST
Viropro, Inc. (OTCBB: VPRO) today announced that its Board of Directors completed its strategic review and has begun the implementation of a restructuring designed to restore the company to financial health.
Viropro Opposes Sale of Alpha Assets by Receiver and Manager Action Follows Seizure of Assets by Bank Pembangunan
PR Newswire - Wed Dec 24, 3:16AM CST
Viropro, Inc. (OTCBB: VPRO) today announced its concern that the proposed sale by a Receiver and Manager appointed by Bank Pembangunan Malaysia Berhad (BPMB) of substantially all the assets of Alpha Biologics Sdn Bhd (Alpha), a wholly owned subsidiary of Viropro located in Penang, Malaysia, would cause irreparable hard to Viropro and the other creditors of Alpha. BPMB previously seized the Alpha facility and appointed Lim San Peen of PricewaterhouseCoopers Advisory Services Sdn Bhd as Receiver and Manager.
